GOSSAMER BIO, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2022-03-03: Form 10-K; Item Well-known seasoned issuer; As filed Yes.
- 2021-11-08: Form 10-Q; Item Smaller reporting company; As filed No.
- 2021-08-09: Form 10-Q; Item Smaller reporting company; As filed No.
- 2021-05-06: Form 10-Q; Item Smaller reporting company; As filed No.
| Filed | Form | Item | As filed |
|---|
| 2022-03-03 | 10-K | Well-known seasoned issuer | Yes |
|---|
| 2021-11-08 | 10-Q | Smaller reporting company | No |
|---|
| 2021-08-09 | 10-Q | Smaller reporting company | No |
|---|
| 2021-05-06 | 10-Q | Smaller reporting company | No |
|---|
| 2021-02-26 | 10-K | Smaller reporting company | No |
|---|
| 2020-11-10 | 10-Q | Smaller reporting company | No |
|---|
| 2020-11-10 | 10-Q | Emerging growth company | Yes |
|---|
| 2020-08-11 | 10-Q | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · GOSS · NASDAQ |
|---|
| 2020-08-11 | 10-Q | Smaller reporting company | No |
|---|
| 2020-08-11 | 10-Q | Emerging growth company | Yes |
|---|
| 2020-05-12 | 10-Q | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · GOSS · NASDAQ |
|---|
| 2020-05-12 | 10-Q | Smaller reporting company | No |
|---|
| 2020-05-12 | 10-Q | Emerging growth company | Yes |
|---|
| 2020-03-24 | 10-K | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · GOSS · NASDAQ |
|---|
| 2020-03-24 | 10-K | Smaller reporting company | No |
|---|
| 2020-03-24 | 10-K | Emerging growth company | Yes |
|---|
| 2019-11-12 | 10-Q | Stock registered under Section 12(b) | Common Stock, $0.0001 par value per share · GOSS · NASDAQ |
|---|
| 2019-11-12 | 10-Q | Smaller reporting company | No |
|---|
| 2019-11-12 | 10-Q | Emerging growth company | Yes |
|---|
| 2019-08-08 | 10-Q | Smaller reporting company | No |
|---|
| 2019-08-08 | 10-Q | Emerging growth company | Yes |
|---|
| 2019-05-14 | 10-Q | Smaller reporting company | No |
|---|
| 2019-05-14 | 10-Q | Emerging growth company | Yes |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|